IGF1 and Insulin resistance: Furthermore, even during the intermittent stages of stressful periods, the catecholamine and cortisol levels in patients with OSAHS are higher than those of individuals in the general population, thereby aggravating insulin resistance and lowering IGF-1 levels (68).